Catalent Pharma Solutions is a finished-dose manufacturer based in United States. It appears in 76 regulatory filings across 9 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO), ARCSA (EC) and MINSA (CR). Its GMP standing is certified by ANVISA (Brazil), MHRA (UK) and US FDA. Its most recent recorded inspection, by US FDA, closed on 30 January 2026 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| KANSAS CITY, United States | Not on file |
| ST PETERSBURG, United States | Not on file |
| WINCHESTER, United States | Not on file |
| NEW JERSEY 08873, United States | Not on file |
| ST. PETERSBURG, United States | Not on file |
| Philadelphia, United States | 3007617094 |
4 further sites are on record.
| Regulator | Filings | GMP certificates |
|---|---|---|
| DIGEMAPS (DO) | 32 | None |
| ARCSA (EC) | 20 | None |
| MINSA (CR) | 10 | None |
| INVIMA (CO) | 5 | None |
| NPRA (MY) | 3 | None |
| EDA (EG) | 2 | None |
| ANVISA (Brazil) | None | 6 |
| MHRA (UK) | None | 5 |
| US FDA | None | 4 |
Choose your molecules and target markets. Catalent Pharma Solutions comes back tiered against every other supplier able to file there.
Start for free